RNA differential display was applied to identify genes critical for the establishment of pregnancy in the mouse. One of the gene fragments identified was homologous to human SC35 splicing factor; the mouse counterpart had not then been cloned. To obtain the full cDNA sequence of the mouse gene, a cDNA library was screened and four positive clones were fully analysed. Sequencing analysis indicated that we had cloned alternatively spliced mRNA species of mouse SC35 splicing factor. A map of splicing structure for this gene's pre-mRNA was then proposed and region-specific mRNA species were tested on Northern blots. This analysis indicated that the overall expression level of SC35 mRNA was much higher in implantation sites than in inter-implantation sites in the mouse uterus during early pregnancy. The expression of alternatively spliced mRNAs for SC35 was differently regulated both during early pregnancy and by steroid hormones. Embryoderived factors were also implicated in the up-regulation of SC35 mRNA at implantation sites. These results demonstrate, for the first time, that an essential splicing factor is regulated in a complex manner during implantation in the mouse uterus. Hence, its correct regulation could be important for the success of pregnancy.
Introduction
. Uterine remodelling at this time is marked by an increase in Embryo implantation is the most relevant factor limiting vascular permeability at implantation sites (Psychoyos, 1973) . successful pregnancy. It is a complex process involving active
We hypothesized that the proliferation and differentiation of interactions between the blastocyst and the uterus. During this endometrial cells at this time are associated with up-or downprocess, the uterus undergoes morphological and physiological regulation of a number of genes, many of which are still changes in a transformation from a non-receptive to a receptive unknown (Nie et al., 1997) . To identify those uterine genes state. The main driving force for this transformation is the which are potentially critical for uterine receptivity, we used ovarian hormones which act through their intracellular recepthe technique of RNA differential display polymerase chain tors to regulate gene expression and hence influence cellular reaction (DDPCR) (Liang and Pardee, 1992, 1993 ) and proliferation and differentiation. In the uterus, it is anticipated compared the mRNA expression pattern of implantation and that a unique set of genes are expressed in a timely manner inter-implantation sites on day 4.5 of pregnancy (Nie et al., during the preparation for receptivity. Indeed, induction of 2000a,b). specific genes including those encoding some growth factors One of the genes identified as being differently regulated and cytokines has been reported in the uterus during the peribetween the two sites was splicing factor SC35, an essential implantation period (Huet-Hudson et al., 1990; Stewart et al., component of the spliceosome. SC35 protein is required for 1992; Robb et al., 1998; Zhu et al., 1998; Das et al., 1999) . the first step in the splicing of precursor mRNAs (Fu and However, given the complexity of the process, the exact Maniatis, 1992a). Gene and cDNA sequences for SC35 splicing molecular events during the uterine transition from the nonfactor in the human have been published (Fu and Maniatis, receptive to receptive state are still not well understood, and 1992b; Sureau and Perbal, 1994) , but in the mouse, the full it is clear that many other molecules critical for implantation cDNA sequence had not been reported and only one short are still unidentified.
partial gene sequence was available (accession no. X98511) In this study, we used the mouse as a model and searched when our studies commenced. To the best of our knowledge, for unrecognized molecules of importance for the very early nothing is known about this splicing factor in the mouse uterus stage of implantation. In the mouse on day 4.5 of pregnancy and in particular in the process of embryo implantation. In the (vaginal plug ϭ day 0), the uterus undergoes dramatic morphopresent investigation, we have cloned alternatively spliced logical changes in association with cell proliferation and differentiation, leading to the acquisition of a receptive state mRNA sequences of mouse SC35 splicing factor and examined their uterine expression during early pregnancy. We also show University animal ethics guidelines on the care and use of laboratory animals. All experimentation was approved by the Institutional Animal Ethics Committee at the Monash Medical Centre. Adult female mice Operon, Alameda, CA, USA), 50 pmol of one oligo-dT anchored (6-8 weeks old) were mated with fertile males of the same strain to primer (as used in cDNA synthesis), 2 αCi of [ 33 P]-dATP (Du Pont produce normal pregnant animals or mated with vasectomized males Australia Ltd, North Sydney, Australia) and 1 IU of Taq DNA to produce pseudopregnant mice. The morning of finding a vaginal polymerase (Boehringer Mannheim). The PCR was performed in a plug was designated as day 0 of pregnancy. Uterine tissues were Hybaid OmniGene PCR system (Hybaid Lit, Middlesex, UK) with collected from non-pregnant mice, pregnant mice on days 3-11 and the following conditions: initial denaturation at 94°C for 5 min; then pseudopregnant mice on days 3-5. A selection of other mouse organs 40 cycles of denaturation at 94°C for 30 s, primer annealing at 39°C was also collected from non-pregnant mice. Tissues were snap-frozen for 2 min and extension at 72°C for 30 s; and a final extension at in liquid nitrogen for Northern blot analysis. Each experiment was 72°C for 10 min. The PCR products (4 µl) were run on a 6% high repeated in three to four animals. resolution polyacrylamide/urea gel and visualized by autoradiography. For non-pregnant, pseudopregnant and 3-day pregnant mice, the The differential display pattern was further confirmed by Northern entire uterus was collected. For 4.5-day pregnant mice, implantation blotting analysis using re-amplified PCR products as probes. Those sites were visualized by i.v. injections of a Chicago blue dye solution bands giving differential expression patterns on the Northern blots (1% in saline, 0.1 ml/mouse) into the tail vein 5 min before killing were sub-cloned into pGEM-T vector (Promega) and sequenced. the animals. Implantation sites were separated from inter-implantation cDNA Library Screening sites and frozen separately. For pregnant mice from day 5.5 onwards, implantation and inter-implantation sites were visualized without To isolate full-length cDNA sequences, a mouse uterus λgt11 cDNA dye injection.
library (Clontech, Palo Alto, CA, USA) was screened with the radioFor non-pregnant mice, the uterus was also collected from different labelled cloned PCR products as probes using standard methods stages of the oestrous cycle: met-oestrus, dioestrus, pro-oestrus and (Sambrook et al., 1989) . In the primary screen~600 000 plaques oestrus. The stages of the cycle were determined by analysis of were screened, and the resultant four positive clones were plated for vaginal smears (Rugh, 1994) . For ovarian hormone treatments, the the second and tertiary screens to get 100% positivity. The positive animals were first ovariectomized under anaesthesia with avertin phage DNA was isolated by the Lambda mini kit (Qiagen Pty Ltd, without regard to the stage of the oestrous cycle (Rugh, 1994) . The Clifton Vic, Australia) and digested with EcoR1 restriction enzyme animals were allowed to rest for 2 weeks, then treated with daily s.c.
to liberate the cDNA insert from the phage; the insert was then subinjections (0.1 ml per mouse) of steroid hormones for 3 days as follows:
cloned into modified pGEM-T easy vector and sequenced as described 17β-oestradiol (100 ng), progesterone (1 mg), or a combination of previously (Nie et al., 2000b) . both hormones. The steroids (Sigma Chemical Co, St Louis, MO, Northern blot and RT-PCR analyses USA) were initially dissolved in minimal amounts of ethanol before dilution in peanut oil. Animals injected with oil alone served as For Northern blot analysis, the basic method was similar to that previcontrols. Mice were killed 24 h after the last injection.
ously published (Nie et al., 2000a) . No attempt was made to separate the embryos from the decidua before day 8 of pregnancy, but for 8-and RNA differential display PCR, re-amplification of cDNAs and 11-day pregnant mice, embryos were separated from the uterine tissue.
sub-cloning
Total RNA (10-15 µg) was denatured at 50°C for 60 min in 50% dimethylsulphoxide (DMSO) and 1 mol/l glyoxal, the denatured RNA RNA differential display polymerase chain reaction (DDPCR) was performed as previously published (Nie et al., 2000b) and as described was fractionated by electrophoresis through a 1.2% agarose gel in 10 mmol/l sodium phosphate buffer (pH 7.0) and transferred to positively originally (Liang and Pardee, 1992, 1993) . Uterine mRNA expression was compared between implantation and inter-implantation sites on charged nylon membranes (Hybond-Nϩ, Amersham, Australia) by overnight capillary blotting in 5ϫ SSPE (1ϫ SSPE ϭ 150 mmol/l day 4.5 of pregnancy in two separate experiments. To avoid embryonic contamination, the embryos were removed under the light microscope NaCl, 10 mmol/l NaH 2 PO 4 , 1 mmol/l EDTA, pH 7.4). Probes were generated by random primer labelling of 25 ng cDNA with [ 32 P]-deoxyfrom the implantation sites. Total RNA (1 µg, DNA-free) from implantation and inter-implantation sites was used as the template CTP (50 µCi/reaction). Unincorporated nucleotides were removed with a MicroSpin S-200 HR column (AMRAD Pharmacia Biotech, for the first-strand cDNA synthesis in a 20 µl reaction mixture in the presence of 20 µmol/l dNTPs, 50 µmol/l oligo-dT anchored primers Melbourne, Australia). To correct lane to lane loading variation, each blot was also probed with a mouse cDNA probe for glyceraldehyde-3-(one of T12 MG, T12MC, T12MA and T12MT, M can be A, G or C), 10 mmol/l dithiothreitol, 10 IU RNasin (Promega, Madison, WI, phosphate dehydrogenase (GAPDH). To validate the proposed splicing structure of mouse SC35 splicing USA), 25 IU AMV reverse transcriptase (Boehringer Mannheim, Nanawading, Victoria, Australia) and cDNA synthesis buffer. The factor primary RNA presented in Figure 4 and Table I , region-specific probes were generated by either restriction enzyme digestion or reverse resultant cDNA was then amplified by PCR in 20 µl with the following components: 2 µl of cDNA, 1ϫ PCR buffer (10 mmol/l transcription (RT)-PCR and tested on Northern blots. The region 1-specific probe was a 345 bp fragment between nucleotides (nt) 115-Tris-HCl, 1.5 mmol/l MgCl 2 , 50 mmol/l KCl, pH 8.3), 10 µmol/l dNTPs, 10 pmol of one random decamer (Operon 10-mer kit A;
459 of MS-SC35. It was generated by RT-PCR of mouse uterine RNA early pregnancy, total RNA from the uterus of non-pregnant mice (at oestrus) and pregnant mice at the initial stage of implantation (day 4.5 of pregnancy) through to fully established placentation (day 10.5 of pregnancy) was analysed by Northern analysis using the 271 bp cDNA of clone 8 as a probe ( Figure 2 ). When the whole uteri were examined before and after pregnancy, it appeared that the expression level was much higher in the pregnant animals. However, it was evident that at around the time of initial embryo attachment and during the actual implantation period (day 4.5-6.5 of pregnancy), the mRNA level in the implantation sites was much higher than that in the inter-implantation sites which displayed expression levels equivalent to that in the non-pregnant uterus. After day sites on this blot was similar to the result shown in Figure 1 when the original DDPCR-derived cDNA fragment was used as probe. regulatory factor (92% over 141 nts, accession no. U14648). Because myelin regulatory factor is a protein closely related
Results
to SC35 splicing factor (Haque et al., 1994) , it was therefore very likely that clone 8 contained the partial cDNA sequence DDPCR results and confirmation by Northern analysis of mouse splicing factor SC35 which had not been reported as being cloned at that time. To identify genes whose expression changes in mouse uterus during the initial implantation process, the gene expression To obtain the full identity of this 271 cDNA fragment and clone the full cDNA sequence of this gene, a λgt11 cDNA pattern of implantation and inter-implantation sites on day 4.5 of pregnancy was compared using the DDPCR technique.
library derived from mouse uterus was screened using the 271 bp cDNA as a probe. Four positive phages were selected Several bands were detected which showed differential expression between implantation and inter-implantation sites. One of from initial screening and subjected to secondary and tertiary screening to gain 100% positivity. The cDNAs were then subthese bands, designated as band 8, was found to be upregulated in the implantation sites. This DDPCR result was cloned into pGEM-T easy vector and designated as clone 8-5 (1835 bp, accession no. AF250135), 8-14 (1162 bp, verified by Northern blot analysis using cDNA extracted from band 8 as a probe (Figure 1 ). On this initial blot, multiple accession no. AF250132), 8-15 (642 bp, accession no. AF250134) and 8-17 (1196 bp, accession no. AF250133) mRNAs were detected with the main transcript being~2.0 kb.
The extracted cDNA of band 8 from the DDPCR gel was respectively. Sequencing analysis revealed differences among these four clones, although all had a similar 3Ј nucleotide re-amplified and cloned into pGEM-T vector. Northern blot analysis was repeated using the cloned inserts as probes and sequence which was homologous (Ͼ99%) to the 271 bp cDNA probe (clone 8). During our efforts to clone the full length clone 8, which contained a cDNA of 271 bp, was confirmed to contain the cDNA representing the original expression cDNA of this gene, a cDNA sequence (1900 bp) of mouse splicing factor SC35 became available in GenBank (accession pattern of band 8 (data not shown).
To systematically determine the expression pattern of this no. AF077858). We designated this published sequence as MS-SC35. Comparison of our sequences with MS-SC35 gene in the uterus in relation to the time of implantation and revealed an interesting but complex alignment map ( Figure  931 , but further towards the 3Ј end from nt 1433 onwards of MS-SC35 ( Figure 4A ). Therefore a section of 502 bp sequence 4A). The shortest (DDPCR-derived) clone 8 (271 bp) aligned (Ͼ99% identity) to the 3Ј ends of all of the longer sequences between and including nt 931-1432 of MS-SC35 was missing in clone 8-5. In addition, clone 8-5 had a longer 3Ј end including the published sequence MS-SC35. Among the four longer clones resulting from the library screening, clone 8-14 compared with the rest of the clones. Furthermore, the initial 277 nucleotides of clone 8-17 which were not found in MS-(1162 bp, accession no. AF250132) was essentially the same as MS-SC35 (Ͼ99.5% identity), but it lacked the 715 bp of SC35 or clone 8-14, aligned perfectly to clone 8-5 (between nt 974-1250). the 5Ј end of MS-SC35 and therefore contained only part of the coding sequence (CDS) ( Figure 4A ). For clone 8-17 (1196 Previous Northern blot analysis detected multiple mRNA species (Figures 1 and 2 ). These bands may represent the bp, accession no. AF250133), from nucleotide 278 onwards its sequence was 100% identical to that of clone 8-14 (from products of alternatively spliced primary RNA of this gene. The above sequence comparison and alignment suggested that its nt 111 onwards), but the initial 277 bp fragment of clone 8-17 was not found in clone 8-14 or MS-SC35. Clone 8-15
we had actually cloned alternatively spliced mRNA forms of mouse SC35 splicing factor. To prove this, we used the (642 bp, accession no. AF250134) contained a shorter sequence of 642 bp and it was identical to the region close to the 3Ј sequence comparison information presented in Figure 4A and tentatively proposed a splicing structure for mouse SC35 end of MS-SC35 (between nt 1066-1708), clone 8-14 (between nt 351-992) and clone 8-17 (between nt 518-1159). Clone splicing factor primary RNA ( Figure 4B and Table I ). We then experimentally validated this hypothesis by Northern 8-5 (1835 bp, accession no. AF250135) was the longest clone obtained from library screening and was the most unusual.
blot analysis. As a proposal for the basic splicing structure for the primary The initial 198 nucleotides (nt 1-198 bp) of clone 8-5 aligned perfectly to nt 628-825 of MS-SC35, but the subsequent 1052 RNA of this gene ( Figure 4B ), we arbitrarily assigned the sequence before nt 825 of MS-SC35 which includes the coding bp nucleotides between and including nt 199-1250 were not found in MS-SC35. After this long unique sequence which sequence (CDS) as one region (region 1) and the rest of the nucleotides which are 3Ј untranslated sequence (UTR) into was absent from MS-SC35 (at its nt 825-826), the immediate following 105 nucleotides (nt between and including 1251-four regions (region 2-5). The sequence before nt 825 of MS-SC35 was proposed as a single region because, firstly, none 1355) of clone 8-5 then perfectly aligned to nt 826-930 of MS-SC35. Interestingly, the remaining sequence from nt 1356 of the clones obtained from library screening showed a splicing site within that section. Secondly, only one mRNA species onwards of clone 8-5 aligned not to the sequence from nt was RT-PCR amplified at that region (data not shown).
and Figure 4 ). The first possibility was represented by clone 8-17, the second by clone 8-5 and the third by clone 8-14. However, analysis of the only available partial gene sequence of mouse SC35 splicing factor (1620 bp, accession no. X98511)
Our cloning experiments did not unveil the existence of the fourth form where only region 3 is spliced out (Table I) . To indicated that the coding region could be thought to consist of two exons. In conjunction with our data, this implied that validate the status of this possible alternatively spliced form, RT-PCR was performed on total RNA isolated from implantaalthough the coding region may consist of two exons, both exons are always present together to form the complete coding tion sites of day 4.5 pregnant uterus with primers across regions 2 and 4 (see Materials and methods section). This region in the final mRNA. Therefore this section of the sequence can be regarded as one unit in terms of the final approach amplified only one type of transcript, all of which included region 3 (data not shown). Therefore, it seems that mRNA format. Thus we decided to assign regions rather than exons to avoid confusion and simplify the splicing structure.
the proposed fourth possible splicing event does not occur in the mouse uterus. Figure 4B is presented in proportion to Figure 4A so that the length and position of each region in Figure 4B can be easily Northern blot analysis to confirm the alternatively referenced to the actual sequences presented in Figure 4A .
spliced mRNAs From our data, most splicing events appear to occur between regions 1 and 5 (Figure 4) . Even though it is difficult to predict Northern blots, prepared from long RNA gels which were run very slowly to separate the multiple bands, were probed with the exact splicing possibilities without the gene sequence, based on our data we can assume that regions 1 (coding cDNAs specific to each region hypothesized in Figure 4B . When a probe specific to region 1 (coding region) which region) and 5 (region with poly (A) tail) are always in the final mRNA. Thus four possible mRNA forms of alternatively included nucleotides between 115 and 459 of MS-SC35 was used, three clear bands at~2.0, 3.2 and 3.5 kb were detected spliced mouse SC35 splicing factor primary RNA could be predicted (Table I ). The first three types have already been ( Figure 5A ). An identical band pattern was obtained with a probe specific to region 5 [region with poly(A) tail; data not confirmed by the cloning and sequencing experiments (Table I Figure 6 . Northern blot analysis of total RNA (15 µg) isolated from whole uterus of non-pregnant mouse at pro-oestrus (pro), oestrus (est), met-oestrus (met) and di-oestrus (die). The top panel shows the signals detected by the region 5-specific probe; the lower panel shows that detected by the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe on the same membrane. 5C), and this is also in close agreement with the prediction (Table I) . These findings clearly supported our hypothesis and prediction, and proved that mouse SC35 splicing factor primary RNA was alternatively spliced, resulting in multiple bands on Northern blots. In addition, the splicing events seem to be the same in both the uterus and the kidney ( Figure 5 ).
In addition, the results presented in Figure 5 confirmed previous findings that the total amount of transcript of SC35 splicing factor was much higher in implantation than interimplantation sites on both day 4.5 and 5.5 of pregnancy. However, it is evident that of the three bands, only the 2.0 kb transcript, which was the most abundant form, showed a clear and consistent pattern of regulation between implantation and To determine the influence of the oestrous cycle on the expression of SC35 splicing factor mRNA in the non-pregnant uterus, total RNA from mice at different stages of the cycle shown]. This finding was in close agreement with the prediction presented in Table I where regions 1 and 5 are present in all (met-oestrus, dioestrus, pro-oestrus and oestrus) was examined by Northern blotting with the region 5-specific probe ( Figure 6 ). three confirmed possible mRNA forms. However, each of the bands on the gel were larger than predicted. It may be that All three bands were detected in all samples, but the expression level, particularly of the 2.0 kb band, changed across the the actual mRNAs in the cell had longer poly A tails than seen by cloning. Furthermore, the region 1 specific probe used cycle. Overall, expression was low at pro-oestrus and oestrus, increased during met-oestrus, and started to decline towards here was not from the library derived clones, but was an RT-PCR fragment close to the 5Ј end of MS-SC35. That both this di-oestrus (Figure 6 ), indicating a likely influence of oestrogen and progesterone on the expression of this gene in the uterus. probe and the region 5-specific probe showed identical band patterns on the Northern blot, unambiguously confirmed that, To verify that the ovarian steroids can regulate the expression of SC35 splicing factor in the uterus, oestradiol and/or progesalthough our library-derived clones did not contain the full length sequence, they were alternatively spliced mRNAs of terone were administered to ovariectomized mice and the expression level was determined by Northern analysis using mouse SC35 splicing factor.
As anticipated (Table I) , when a probe specific to region 2 the probe specific to region 5 (Figure 7) . The ovariectomized mice treated with vehicle (oil) showed very low expression of was used on Northern blots, only the two larger bands were detected ( Figure 5B ). When a probe specific to region 4 was SC35 splicing factor mRNA. Animals treated with oestradiol alone had the same level of expression as the controls while used, only the largest and smallest bands were detected ( Figure Figure 7 . Northern blot analysis of total RNA (15 µg) isolated from whole uterus of ovariectomized mice injected with vehicle (oil), 17β-oestradiol (E), progesterone (P) or oestradiol and Figure 9 . Northern blot analysis of the tissue specificity of mouse progesterone (EϩP). The top panel shows the signals detected by SC35 splicing factor mRNA. Total RNA was isolated from mouse the region 5-specific probe; the lower panel shows that detected by muscle, whole brain, spleen, heart, testis, ovary, uterus the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe on (implantation sites on day 5.5 pregnancy) intestine and lung. 15 µg the same membrane.
of total RNA was loaded in each lane. The panel shows the signals detected by region 5-specific probe.
low. Under pseudopregnant conditions, on both day 3.5 and 4.5, the uterus showed very low expression of SC35 splicing factor mRNA, with a value equivalent to that of interimplantation sites of actual pregnancy (Figure 8 ). Thus the observed high expression of SC35 splicing factor mRNA during early pregnancy appears to be embryo-dependent.
Tissue distribution of SC35 splicing factor mRNA
Multi-tissue Northern analysis was performed to investigate whether the expression of SC35 splicing factor mRNA was specific to uterus ( Figure 9 ). The mRNA was detected using region 5 specific probe in all of the samples examined, indicating that it is widely expressed. The 2.0 kb band was predominant in all tissues examined. The expression level was The DDPCR technique has been extensively used to identify differentially regulated genes in a number of biological systems (Everett et al., 1997; Kothapalli et al., 1997; Das et al., 1999) . those treated with progesterone had much higher expression compared with the control or oestradiol-treated animals.
We applied this technique to search for genes which are differentially expressed between implantation and interAnimals treated with both steroids showed less response. Both the 2.0 kb and 3.5 kb bands showed changes, but only the 2.0 kb implantation sites in the mouse uterus on day 4.5 of pregnancy when the uterus shows the first morphological changes associband was found to show consistent and reproducible changes. ated with pregnancy. We reasoned that up-or down-regulation Effects of the embryo on uterine expression of SC35 of these genes would be potentially important for conversion splicing factor of the uterus from the non-receptive to the receptive state. We detected several bands exhibiting different expression between To determine whether the presence of embryos in the uterus was essential for the observed changes in SC35 splicing factor the two sites, one of which we identified as mouse SC35 splicing factor. mRNA during early pregnancy, total RNA was isolated from mice on day 3.5 and 4.5 of pseudopregnancy and the expression The mRNA expression of this splicing factor was much higher in implantation sites than in inter-implantation sites pattern compared with that in pregnant animals by Northern analysis (Figure 8 ). As seen previously ( Figure 5 ), a high level during early pregnancy. In the pseudopregnant uterus, the level was low and equivalent to that in the inter-implantation sites of expression of the 2.0 kb transcript was detected on both day 3.5 and 4.5 of normal pregnancy. Furthermore, on day 4.5 of pregnant mice. This suggests that SC35 splicing factor mRNA is tightly regulated during early pregnancy, and that this high expression was seen only in the implantation sites while the expression in the inter-implantation sites was very its pregnancy-related expression is dependent upon the presence of blastocysts in the uterus. The observed unique expression can be predicted that correct expression of SC35 splicing factor in the uterus at implantation sites is pivotal, controlling pattern of this splicing factor suggests that it plays an important role in the implantation process.
the correct expression of other proteins important for implantation. In addition, due to the concentration-dependent action of The removal of introns from pre-mRNA precursors by splicing is a fundamental process controlling gene expression SC35 splicing factor in the splicing event (Fu et al., 1992) , higher expression of this splicing factor at implantation sites during differentiation and development, and is an essential and often regulated step in the expression of eukaryotic genes may also influence the pattern of the alternative splicing of other genes. (Rio, 1992) . Nuclear pre-mRNA splicing takes place in a multi-component structure termed the spliceosome, a high This study also attempted to determine the full cDNA sequence of mouse uterine SC35 splicing factor by screening molecular weight complex containing small nuclear ribonucleoprotein (snRNP) particles and several non-snRNP protein a cDNA library using the DDPCR derived short cDNA as a probe. Four longer positive clones were fully sequenced and components (Rio, 1992) . These non-snRNP proteins are designated as SR proteins because they have one or two copies of analysed. Strikingly, although all of these had common 3Ј ends, they were not identical. When these four clones were the RNA recognition motif (RRM) and contain regions rich in arginine and serine residues (RS domains). SC35 splicing compared with the newly available sequence of mouse SC35 splicing factor, MS-SC35 (Yang et al., 1998) , a complex but factor is one of these non-snRNP proteins and a member of the SR protein family; it has also been termed PR264 (Vellard interesting alignment map was obtained. This map strongly suggested that these four library-derived clones represented et al., 1992). SC35 splicing factor is an important component for constitutive splicing of precursor mRNAs (Fu et al., 1992;  alternatively spliced forms of SC35 splicing factor pre-mRNA. Based on the sequence analyses of all clones related to mouse Fu and Maniatis, 1992a) . Among the SR family members, ASF/SF2 and SC35 exhibit different substrate specificities SC35 splicing factor, we proposed a splicing structure for the pre-mRNA of this protein which was then successfully validsuggesting they are non-redundant components of the splicing machinery (Gallego et al., 1997) . Furthermore, it has been ated by Northern blotting with region specific probes. The multiple bands seen on the Northern blots were confirmed to suggested that the relative abundance of each SR protein and the molar ratio of each SR protein to snRNP (e.g. the A1 type) be alternatively spliced forms of the same pre-mRNA. To the best of our knowledge, no previous publication has addressed may determine the patterns of alternative splicing of many genes expressed in a particular cell type (Caceres et al., 1994) the phenomenon of alternative splicing for this protein in the mouse. Interestingly, this resembles very closely the situation and influence the selection of alternative splice sites in a concentration-dependent manner (Fu et al., 1992;  Caceres in the human. Several bands were similarly detected on Northern blots for human SC35 splicing factor and were et al., 1994).
The concept that correct expression of splicing regulatory established to result from alternative splicing of the pre-mRNA (Sureau and Perbal, 1994) . These alternatively spliced mRNAs, factors is crucial for proper cell function and development has been illustrated in a number of physiological and pathological also with various lengths of the 3Ј UTR of SC35 splicing factor, were further demonstrated to exhibit significantly different halfconditions including blastocyst formation in the mouse (Jumaa et al., 1999) and control of the proliferative lifespan and lives (Sureau and Perbal, 1994) . This feature is likely to also hold in the mouse. Expression of multiple mRNAs of this senescence of cells (Ito et al., 1998) . Furthermore, irregular expression of splicing regulatory factors might be one of the splicing factor with different stability may be one of the mechanisms by which cells modulate the amount of SC35 causes for aberrant expression of alternatively spliced mRNAs in tumour cells (Maeda et al., 1999) . Changes in the expression splicing factor and, thereby, allow specific concentrationdependent splicing reactions. Our preliminary data (not shown) of the SR family members has been demonstrated during mammary tumorigenesis, and this leads to alterations in the also suggests the same characteristic of splicing events for SC35 splicing factor in non-human primates. Therefore, it normal splicing of a number of pre-mRNAs (Stickeler et al., 1999) . The expression of SC35 splicing factor is also seems that alternative splicing of its pre-mRNA is a common feature for this splicing factor across species. altered after human immunodeficiency virus (HIV) infection (Maldarelli et al., 1998) , indicating that HIV modifies the This is the first report demonstrating alterations in expression of a factor critical for pre-mRNA splicing at the time of expression of genes in a normal cell by affecting the splicing machinery. Thus, it is clear that splicing of pre-mRNA can be embryo implantation. It also provides the first evidence that splicing factor SC35 mRNA is regulated both by blastocyst an important controlling point in the regulation of cell function and pathogenesis. signals and ovarian hormones. How steroid hormones might regulate the expression of splicing factor SC35 is not clear, The high expression of SC35 splicing factor mRNA at implantation sites during early pregnancy correlates well with as no perfect hormone response elements for oestrogen or progesterone can be found on the limited short promoter the expression of many implantation-related genes (HuetHudson et al., 1990; Stewart et al., 1992; Bigsby and Li, sequence available for this factor. Such hormonal regulation can be both cell-type and/or species specific. Several alternatively 1994; Kraus et al., 1994; Everett et al., 1997; Das et al., 1997 Das et al., , 1999 Robb et al., 1998; Zhu et al., 1998) . As many of these spliced variants of SC35 mRNA are present in the uterus and it is apparent that not all of these are modulated in the genes contain introns, correct processing of their pre-mRNAs by splicing mechanisms is clearly important for the accurate same manner between implantation and inter-implantation sites during early pregnancy. The dominant band at 2.0 kb appears expression of vital proteins during early pregnancy. Thus, it
